
Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.

Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.
See how a mechanistic QSP platform captures disease progression and treatment response to enable better…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
News China’s National Medical Products Administration (NMPA) has authorized an implantable brain-computer interface (BCI) designed to help people with severe…
News Flatiron Health has launched six new hematology datasets built using AI and large language models (LLMs), unlocking longitudinal clinical…
Interface of retinal pigment epithelium and photoreceptor cells. Source: NIH Open-i As we discussed in our December 17, 2015…
News Five pharmaceutical companies, including Lundbeck, Orion Pharma, Recursion, Servier, and one undisclosed organization, have committed around 80% of their…
Sign in to your account